Centro de Neurología Avanzada
- Address
- Avenida Manuel Siurot 43a, 41013 Seville, Spain
Neurology and Nervous System Diseases
At Centro de Neurología Avanzada in Sevilla, the clinical trial program focuses on neurological disorders, especially epilepsy and related seizure conditions. The research is centered on testing new therapies, assessing seizure control, and improving the safety and tolerability of treatments for people living with challenging nervous system diseases.
- Studies in adult focal epilepsy and refractory focal onset epilepsy are evaluating whether new add-on treatments can reduce seizure frequency and improve overall control.
- Research in idiopathic generalized epilepsy with generalized tonic-clonic seizures is examining treatment effectiveness and safety in a difficult-to-manage form of epilepsy.
- Trials in Lennox-Gastaut syndrome and tuberous sclerosis complex are exploring therapies aimed at better seizure management and symptom relief.
- Several studies are also looking at rapid treatment options for stereotypical prolonged seizure episodes, with attention to fast seizure termination and prevention of recurrence.
Overall, the site’s research landscape is strongly dedicated to advancing epilepsy care, with a clear emphasis on treatment effectiveness, safety, and practical options for patients with persistent seizures.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1UCB Biopharma2active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Biohaven Therapeutics Ltd.3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centro de Neurología Avanzada
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy and Safety of Clemizole Hydrochloride as Adjunctive Therapy in Patients with Lennox-Gastaut Syndrome | Epygenix Therapeutics Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 6 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Bhv-7000 | 3 | Unknown | 2024-09-25 | 2024-12-18 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.